333 related articles for article (PubMed ID: 11031826)
1. [Plasma cardiac natriuretic peptide as a biological marker of recurrence of atrial fibrillation in elderly people].
Mabuchi N; Tsutamoto T; Maeda K; Masahiko K
Nihon Ronen Igakkai Zasshi; 2000 Jul; 37(7):535-40. PubMed ID: 11031826
[TBL] [Abstract][Full Text] [Related]
2. Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure.
Mabuchi N; Tsutamoto T; Maeda K; Kinoshita M
Jpn Circ J; 2000 Oct; 64(10):765-71. PubMed ID: 11059617
[TBL] [Abstract][Full Text] [Related]
3. The effects of left ventricular diastolic function on natriuretic peptide levels after cardioversion of atrial fibrillation.
Bakowski D; Wozakowska-Kapłon B; Opolski G
Kardiol Pol; 2009 Apr; 67(4):361-7. PubMed ID: 19492248
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation.
Shimamoto K; Kusumoto M; Sakai R; Watanabe H; Ihara S; Koike N; Kawana M
Can J Cardiol; 2007 Mar; 23(4):295-300. PubMed ID: 17380223
[TBL] [Abstract][Full Text] [Related]
5. The influence of left ventricle diastolic function on natriuretic peptides levels in patients with atrial fibrillation.
Bakowski D; Wozakowska-Kaplon B; Opolski G
Pacing Clin Electrophysiol; 2009 Jun; 32(6):745-52. PubMed ID: 19545336
[TBL] [Abstract][Full Text] [Related]
6. Decreased plasma brain natriuretic peptide levels after a successful maze procedure.
Watanabe M; Murakami M; Furukawa H; Nakahara H; Tanaka H; Sunamori M
J Heart Valve Dis; 2003 May; 12(3):287-91. PubMed ID: 12803326
[TBL] [Abstract][Full Text] [Related]
7. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.
Rienstra M; Van Gelder IC; Van den Berg MP; Boomsma F; Van Veldhuisen DJ
Europace; 2006 Jul; 8(7):482-7. PubMed ID: 16798760
[TBL] [Abstract][Full Text] [Related]
8. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.
Wozakowska-Kapłon B; Opolski G
Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231
[TBL] [Abstract][Full Text] [Related]
9. Plasma biomarkers as predictors of recurrence of atrial fibrillation.
Lewicka E; Dudzińska-Gehrmann J; Dąbrowska-Kugacka A; Zagożdżon P; Stepnowska E; Liżewska A; Kozłowski D; Raczak G
Pol Arch Med Wewn; 2015; 125(6):424-33. PubMed ID: 26038944
[TBL] [Abstract][Full Text] [Related]
10. Plasma atrial natriuretic Peptide and brain natriuretic Peptide levels after radiofrequency catheter ablation of atrial fibrillation.
Yamada T; Murakami Y; Okada T; Okamoto M; Shimizu T; Toyama J; Yoshida Y; Tsuboi N; Ito T; Muto M; Kondo T; Inden Y; Hirai M; Murohara T
Am J Cardiol; 2006 Jun; 97(12):1741-4. PubMed ID: 16765125
[TBL] [Abstract][Full Text] [Related]
11. ANP and BNP in atrial fibrillation before and after cardioversion--and their relationship to cardiac volume and function.
Therkelsen SK; Groenning BA; Kjaer A; Svendsen JH; Boje Jensen G
Int J Cardiol; 2008 Jul; 127(3):396-9. PubMed ID: 17628724
[TBL] [Abstract][Full Text] [Related]
12. Brain natriuretic peptide predicts chronic atrial fibrillation after ventricular pacing in patients with sick sinus syndrome.
Horie H; Tsutamoto T; Minai K; Hayashi M; Kito O; Kinoshita M
Jpn Circ J; 2000 Dec; 64(12):965-70. PubMed ID: 11194292
[TBL] [Abstract][Full Text] [Related]
13. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
[TBL] [Abstract][Full Text] [Related]
14. BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.
Falcão LM; Pinto F; Ravara L; van Zwieten PA
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):121-9. PubMed ID: 15526247
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentration of atrial natriuretic peptide is related to the duration of atrial fibrillation in patients with advanced heart failure.
Wozakowska-Kapłon B; Opolski G; Janion M; Kosior D
Kardiol Pol; 2004 Dec; 61(12):513-21; discussion 522. PubMed ID: 15815752
[TBL] [Abstract][Full Text] [Related]
16. The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure.
Lee SC; Stevens TL; Sandberg SM; Heublein DM; Nelson SM; Jougasaki M; Redfield MM; Burnett JC
J Card Fail; 2002 Jun; 8(3):149-54. PubMed ID: 12140807
[TBL] [Abstract][Full Text] [Related]
17. [Factors that influence the serum of atrial natriuretic peptide and brain natriuretic peptide concentrations--is there a specific marker for senile patients?].
Sayama H; Nakamura Y; Saitou N; Doi Y; Matsukura S; Sakurai H; Kinoshita M
Nihon Ronen Igakkai Zasshi; 1998 Nov; 35(11):851-7. PubMed ID: 10064973
[TBL] [Abstract][Full Text] [Related]
18. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation.
Inoue S; Murakami Y; Sano K; Katoh H; Shimada T
J Card Fail; 2000 Jun; 6(2):92-6. PubMed ID: 10908082
[TBL] [Abstract][Full Text] [Related]
19. The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion.
Ari H; Binici S; Ari S; Akkaya M; Koca V; Bozat T; Gürdoğan M
Turk Kardiyol Dern Ars; 2008 Oct; 36(7):456-60. PubMed ID: 19155659
[TBL] [Abstract][Full Text] [Related]
20. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
